BiotechTube
Home/Mid-Atlantic Biotherapeutics/Matthew Duncton
MD

Matthew Duncton

Scientific Leader (via XPose)

Mid-Atlantic Biotherapeutics

Therapeutic Areas

OncologyNeurologyInfectious Disease

Mid-Atlantic Biotherapeutics Pipeline

DrugIndicationPhase
IMT504-based ProgramRabiesNot Specified (Orphan Designated)
Neurology ProgramsAlzheimer's Disease, Parkinson's Disease, ALSPre-clinical
XPose DDR ProgramsOvarian, Breast, Lung, Brain CancersPre-clinical

Leadership Team at Mid-Atlantic Biotherapeutics

DH
David Horn
CEO & Founder
DJ
Dave Jobes
President & Co-Founder
JG
Jean-Pierre Gagnon
Senior VP of Operations & Co-Founder
DD
Debanu Das
Scientific Leader (via XPose)
View full Mid-Atlantic Biotherapeutics profile